Justin McLaughlin 5/17/22 Justin McLaughlin 5/17/22 Dose-Limiting Toxicities (DLTs) in Phase 1 Clinical Studies – Prepare for Regulatory Success Read More Justin McLaughlin 1/25/22 Justin McLaughlin 1/25/22 How to Write CSR Conclusions Read More Justin McLaughlin 12/30/21 Justin McLaughlin 12/30/21 What a Real Submission Timeline Looks Like Read More
Justin McLaughlin 5/17/22 Justin McLaughlin 5/17/22 Dose-Limiting Toxicities (DLTs) in Phase 1 Clinical Studies – Prepare for Regulatory Success Read More
Justin McLaughlin 12/30/21 Justin McLaughlin 12/30/21 What a Real Submission Timeline Looks Like Read More
